Evidence map›Paper›PMID 34258157›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Delivering Antisense Oligonucleotides across the Blood-Brain Barrier by Tumor Cell-Derived Small Apoptotic Bodies.

Yulian Wang, Jiayun Pang, Qingyun Wang, Luocheng Yan, Lintao Wang, Zhen Xing, Chunming Wang, Junfeng Zhang, Lei Dong

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Apoptotic body-encapsulated zinc-dopedMaterials today. Bio · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Astrocytic BEST1 can serve as a target for functional recovery after ischemic stroke.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yulian WangState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Jiayun PangState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Qingyun WangState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Luocheng YanState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Lintao WangState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Zhen XingState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Chunming WangState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macau SAR 999078 China.
Junfeng ZhangState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.
Lei DongState Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University 163 Xianlin Avenue Nanjing 210093 China.ORCID 0000-0002-2013-4191
Nanjing University · CNUniversity of Macau · MONanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain barrier (BBB) is the most restrictive and complicated barrier that keeps most biomolecules and drugs from the brain. An efficient brain delivery strategy is urgently needed for the treatment of brain diseases. Based on the studies of brain-targeting extracellular vesicles (EVs), the potential of using small apoptotic bodies (sABs) from brain metastatic cancer cells for brain-targeting drug delivery is explored. It is found that anti-TNF-

Indexed as

AnimalsBlood-Brain BarrierBrain NeoplasmsDisease Models, AnimalExtracellular VesiclesMaleMannansMiceMice, Inbred C57BLOligonucleotides, AntisenseThionucleotides(1-6)-alpha-glucomannanMannansOligonucleotides, AntisenseThionucleotidesblood‐brain barrierCD44v6small apoptotic bodiestranscytosistumor cells

Identifiers

PMID34258157
PMCPMC8261483
OpenAlexW3159490848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.